CMF12 Nonthyroidal Illness Syndrome: To Treat or Not?

Program: Case Management Forums
Clinical Session
Monday, April 4, 2016: 9:00 AM-9:45 AM
Room 210 (BCEC)
Gregory A Brent, MD, Veterans Affairs Greater Los Angeles Healthcare System and David Geffen School of Medicine at UCLA, Tarzana, CA and Alan P. Farwell, MD, Boston Medical Center, Boston, MA

Nothing to Disclose: GAB, APF
See more of: Case Management Forums


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire